News

BioStat® Research
& Development Centre

2024 2023 2022 older
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
06
February
2019
We develop the collaboration with Polish gastroenterology
06
February
2019

We develop the collaboration with Polish gastroenterology

Nowadays, as there is a high risk of turmoil and business instability, we have a strong advantage in creating an unconventional business model what results in enlarging the range of our long-standing Clients.

Every day, our company makes every effort to develop our unique and at the same time strategic position, that would help us distinguish ourselves among the companies with a similar business profile. Our key to this strategy is a reasonable selection of teams and sets of activities that would guarantee an inimitable set of benefits for our clients. The proof for our effective strategy is yet another collaboration of BioStat® with the representatives from the Polish Association of Gastroenterology and Egis company that supports the whole project.

We are aware of the fact that each strategy cannot last forever, therefore, we do not rest on our laurels and continuously develop our competencies in a way that we could guarantee 100% satisfaction to our Clients and Business Partners.

 

Copyright© 2023 Biostat
Cookies